About Elliot
Elliot Shapiro's practice is transaction oriented, with a focus on corporate and securities law, public and private mergers and acquisitions (M&A), infrastructure and P3 financing as well as venture capital financing transactions. Mr. Shapiro also regularly advises public companies and their boards of directors on strategic, disclosure and governance matters. He has also worked on various licensing and related commercial arrangements. Mr. Shapiro has been integrally involved in numerous cross-border Canada-US corporate finance transactions both on a public and private placement basis as well as a range of public and private M&A transactions.Mr. Shapiro is co-chair of our Canadian corporate finance and securities team and a member of the Corporate Finance Advisory Committee of the Quebec Autorité des marchés financiers. Mr. Shapiro also serves as a member of Norton Rose Fulbright's Canadian Risk and Audit Committee. He previously served for over 5 years as corporate secretary of Aeterna Zentaris Inc., a specialty biopharmaceutical company traded on the Toronto Stock Exchange and the Nasdaq Capital Market.Prior to joining our Montréal office, Mr. Shapiro worked as a research assistant for Professor William Tetley, Q.C. in maritime and private international law. He is fluent in English, French and Polish.
Elliot Shapiro's practice is transaction oriented, with a focus on corporate and securities law, public and private mergers and acquisitions (M&A), infrastructure and P3 financing as well as venture capital financing transactions. Mr. Shapiro also regularly advises public companies and their boards of directors on strategic, disclosure and governance matters. He has also worked on various licensing and related commercial arrangements. Mr. Shapiro has been integrally involved in numerous cross-border Canada-US corporate finance transactions both on a public and private placement basis as well as a range of public and private M&A transactions.Mr. Shapiro is co-chair of our Canadian corporate finance and securities team and a member of the Corporate Finance Advisory Committee of the Quebec Autorité des marchés financiers. Mr. Shapiro also serves as a member of Norton Rose Fulbright's Canadian Risk and Audit Committee. He previously served for over 5 years as corporate secretary of Aeterna Zentaris Inc., a specialty biopharmaceutical company traded on the Toronto Stock Exchange and the Nasdaq Capital Market.Prior to joining our Montréal office, Mr. Shapiro worked as a research assistant for Professor William Tetley, Q.C. in maritime and private international law. He is fluent in English, French and Polish.
